Ixazomib Alternatives Compared
Ixazomib | Tecvayli | Revlimid |
|
---|
Ixazomib | Tecvayli (teclistamab) | Revlimid (lenalidomide) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Multiple Myeloma. ixazomib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Multiple Myeloma. Tecvayli may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Follicular Lymphoma, Mantle Cell Lymphoma, Anemia, Lymphoma, Marginal Zone Lymphoma, Multiple Myeloma, Myelodysplastic Diseases. Revlimid may also be used for purposes not listed in... View more |
Related suggestions Multiple Myeloma
|
|||||||||||||||
More about Ixazomib | More about Tecvayli (teclistamab) | More about Revlimid (lenalidomide) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Ixazomib has an average rating of 4.7 out of 10 from a total of 3 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 33% reported a negative effect. |
Tecvayli has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Revlimid has an average rating of 7.2 out of 10 from a total of 26 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 18% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See also: ixazomib side effects in more detail. |
See also: Tecvayli side effects in more detail. |
See also: Revlimid side effects in more detail. |
||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
N/A |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Tecvayli prices |
View all Revlimid prices |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
N/A |
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Ninlaro |
N/A |
N/A |
||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
228 hours |
N/A |
3 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 330 drugs are known to interact with ixazomib:
|
A total of 402 drugs are known to interact with Tecvayli:
|
A total of 274 drugs are known to interact with Revlimid:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
November 20, 2015 |
October 25, 2022 |
December 27, 2005 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.